The SELECT trial of semaglutide in patients with overweight or obesity without diabetes: establishing a new pathway to secondary prevention of cardiovascular disease.
| Autor: | Lincoff AM; Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA., Ryan DH; Pennington Biomedical Research Center, Baton Rouge, LA, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | European heart journal. Cardiovascular pharmacotherapy [Eur Heart J Cardiovasc Pharmacother] 2024 Feb 23; Vol. 10 (2), pp. 93-94. |
| DOI: | 10.1093/ehjcvp/pvad097 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|